TX
Texas Senate Bill SB263

Texas 2013 - 83rd Regular

Texas Senate Bill SB263 Compare Versions

The same version is selected twice. Please select two different versions to compare.
OldNewDifferences
11 By: Huffman S.B. No. 263
22 (Carter, Price)
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to the designation for criminal prosecution and other
88 purposes of certain chemicals commonly referred to as synthetic
99 cannabinoids as controlled substances and controlled substance
1010 analogues under the Texas Controlled Substances Act.
1111 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1212 SECTION 1. Subdivisions (5) and (6), Section 481.002,
1313 Health and Safety Code, are amended to read as follows:
1414 (5) "Controlled substance" means a substance,
1515 including a drug, an adulterant, and a dilutant, listed in
1616 Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A,
1717 3, or [through] 4. The term includes the aggregate weight of any
1818 mixture, solution, or other substance containing a controlled
1919 substance.
2020 (6) "Controlled substance analogue" means:
2121 (A) a substance with a chemical structure
2222 substantially similar to the chemical structure of a controlled
2323 substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or
2424 2-A; or
2525 (B) a substance specifically designed to produce
2626 an effect substantially similar to, or greater than, the effect of a
2727 controlled substance in Schedule I or II or Penalty Group 1, 1-A,
2828 [or] 2, or 2-A.
2929 SECTION 2. Section 481.1031, Health and Safety Code, is
3030 amended to read as follows:
3131 Sec. 481.1031. PENALTY GROUP 2-A. Penalty Group 2-A
3232 consists of any material, compound, mixture, or preparation that
3333 contains any quantity of a synthetic chemical substance, including
3434 its salts, isomers, and salts of isomers, listed by name in this
3535 section or contained within the following structural classes
3636 defined in this section [compound that is a cannabinoid receptor
3737 agonist and mimics the pharmacological effect of naturally
3838 occurring cannabinoids, including]:
3939 WIN-55,212-2;
4040 Naphthoylindole: any compound [naphthoylindoles]
4141 structurally derived from 3-(1-naphthoyl)indole or
4242 3-(2-naphthoyl)indole by substitution at the nitrogen atom of the
4343 indole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
4444 haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
4545 cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
4646 (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl
4747 [2-(4-morpholinyl)ethyl], whether or not further substituted in
4848 the indole ring to any extent, whether or not substituted in the
4949 naphthyl [napthyl] ring to any extent, including:
5050 AM-1220;
5151 AM-2201;
5252 JWH-004;
5353 JWH-007;
5454 JWH-009;
5555 JWH-015;
5656 JWH-016;
5757 JWH-018;
5858 JWH-019;
5959 JWH-020;
6060 JWH-046;
6161 JWH-047;
6262 JWH-048;
6363 JWH-049;
6464 JWH-050;
6565 JWH-073;
6666 JWH-076;
6767 JWH-079;
6868 JWH-080;
6969 JWH-081;
7070 JWH-082;
7171 JWH-083;
7272 JWH-093;
7373 JWH-094;
7474 JWH-095;
7575 JWH-096;
7676 JWH-097;
7777 JWH-098;
7878 JWH-099;
7979 JWH-100;
8080 JWH-116;
8181 JWH-122;
8282 JWH-148;
8383 JWH-149;
8484 JWH-153;
8585 JWH-159;
8686 JWH-164;
8787 JWH-165;
8888 JWH-166;
8989 JWH-180;
9090 JWH-181;
9191 JWH-182;
9292 JWH-189;
9393 JWH-193;
9494 JWH-198;
9595 JWH-200;
9696 JWH-210;
9797 JWH-211;
9898 JWH-212;
9999 JWH-213;
100100 JWH-234;
101101 JWH-235;
102102 JWH-239;
103103 JWH-240;
104104 JWH-241;
105105 JWH-242;
106106 JWH-258;
107107 JWH-259;
108108 JWH-260;
109109 JWH-262;
110110 JWH-267;
111111 JWH-386;
112112 JWH-387;
113113 JWH-394;
114114 JWH-395;
115115 JWH-397;
116116 JWH-398;
117117 JWH-399;
118118 JWH-400;
119119 JWH-412;
120120 JWH-413; and
121121 JWH-414;
122122 Naphthylmethylindole: any compound
123123 [naphthylmethylindones] structurally derived from
124124 1H-indol-3-yl-(1-naphthyl)methane or
125125 1H-indol-3-yl-(2-naphthyl)methane by substitution at the nitrogen
126126 atom of the indole ring by alkyl, haloalkyl, benzyl, halobenzyl,
127127 alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl,
128128 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
129129 (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl
130130 [2-(4-morpholinyl)ethyl], whether or not further substituted in
131131 the indole ring to any extent, whether or not substituted in the
132132 naphthyl ring to any extent, including:
133133 JWH-175;
134134 JWH-184;
135135 JWH-185;
136136 JWH-192;
137137 JWH-194;
138138 JWH-195;
139139 JWH-196;
140140 JWH-197; and
141141 JWH-199;
142142 Naphthylindolecarboxamide: any compound structurally
143143 derived from N-(naphthalen-1-yl)-1H-indole-3-carboxamide or
144144 N-(naphthalen-2-yl)-1H-indole-3-carboxamide by substitution at
145145 the nitrogen atom of the indole ring by alkyl, haloalkyl, benzyl,
146146 halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
147147 hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
148148 (N-methylpiperidin-2-yl)alkyl or 2-(4-morpholinyl)alkyl, whether
149149 or not further substituted in the indole ring to any extent, whether
150150 or not substituted in the naphthyl ring to any extent, including:
151151 MN-24 (Other name: NNEI);
152152 Naphthoylpyrrole: any compound [naphthoylpyrroles]
153153 structurally derived from 3-(1-naphthoyl)pyrrole or
154154 3-(2-naphthoyl)pyrrole by substitution at the nitrogen atom of the
155155 pyrrole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
156156 haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
157157 cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
158158 (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl
159159 [2-(4-morpholinyl)ethyl], whether or not further substituted in
160160 the pyrrole ring to any extent, whether or not substituted in the
161161 naphthyl ring to any extent, including:
162162 JWH-030;
163163 JWH-145;
164164 JWH-146;
165165 JWH-147;
166166 JWH-150;
167167 JWH-156;
168168 JWH-243;
169169 JWH-244;
170170 JWH-245;
171171 JWH-246;
172172 JWH-292;
173173 JWH-293;
174174 JWH-307;
175175 JWH-308;
176176 JWH-309;
177177 JWH-346;
178178 JWH-347;
179179 JWH-348;
180180 JWH-363;
181181 JWH-364;
182182 JWH-365;
183183 JWH-366;
184184 JWH-367;
185185 JWH-368;
186186 JWH-369;
187187 JWH-370;
188188 JWH-371;
189189 JWH-372;
190190 JWH-373; and
191191 JWH-392;
192192 Naphthylmethylindene: any compound
193193 [naphthylmethylindenes] structurally derived from
194194 1-(1-naphthylmethyl)indene or 1-(2-naphthylmethyl)indene by
195195 substitution at the 3-position of the indene ring by alkyl,
196196 haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
197197 cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
198198 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
199199 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl], whether or not
200200 further substituted in the indene ring to any extent, whether or not
201201 substituted in the naphthyl ring to any extent, including:
202202 JWH-171;
203203 JWH-172;
204204 JWH-173; and
205205 JWH-176;
206206 Phenylacetylindole: any compound [phenylacetylindoles]
207207 structurally derived from 3-phenylacetylindole by substitution at
208208 the nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl,
209209 halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
210210 hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
211211 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
212212 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl], whether or not
213213 further substituted in the indole ring to any extent, whether or not
214214 substituted in the phenyl ring to any extent, including:
215215 [AM-694;
216216 [AM-1241;]
217217 JWH-167;
218218 JWH-203;
219219 JWH-204;
220220 JWH-205;
221221 JWH-206;
222222 JWH-208;
223223 JWH-237;
224224 JWH-248;
225225 JWH-249;
226226 JWH-250;
227227 JWH-251;
228228 JWH-252;
229229 JWH-253;
230230 JWH-302;
231231 JWH-303;
232232 JWH-305;
233233 JWH-306;
234234 JWH-311;
235235 JWH-312;
236236 JWH-313;
237237 JWH-314; [and]
238238 JWH-315; and
239239 RCS-8;
240240 Benzoylindole: any compound structurally derived from
241241 3-benzoylindole by substitution at the nitrogen atom of the indole
242242 ring with alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
243243 haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
244244 cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
245245 (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or
246246 not further substituted in the indole ring to any extent, whether or
247247 not substituted in the phenyl ring to any extent, including:
248248 AM-630;
249249 AM-679;
250250 AM-694;
251251 AM-1241;
252252 Pravadoline (Other name: WIN 48,098); and
253253 RCS-4;
254254 Adamantoylindole: any compound structurally derived
255255 from 3-(1-adamantoyl)indole or 3-(2-adamantoyl)indole by
256256 substitution at the nitrogen atom of the indole ring with alkyl,
257257 haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
258258 cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
259259 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
260260 2-(4-morpholinyl)alkyl, whether or not further substituted in the
261261 indole ring to any extent, whether or not substituted in the
262262 adamantyl ring to any extent, including:
263263 AB-001; and
264264 AM-1248;
265265 Adamantylindolecarboxamide: any compound structurally
266266 derived from N-(adamantan-1-yl)-1H-indole-3-carboxamide or
267267 N-(adamantan-2-yl)-1H-indole-3-carboxamide by substitution at the
268268 nitrogen atom of the indole ring by alkyl, haloalkyl, benzyl,
269269 halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
270270 hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
271271 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
272272 2-(4-morpholinyl)alkyl, whether or not further substituted in the
273273 indole ring to any extent, whether or not substituted in the
274274 adamantyl ring to any extent, including:
275275 APICA; and
276276 STS-135;
277277 Adamantylindazolecarboxamide: any compound
278278 structurally derived from
279279 N-(adamantan-1-yl)-1H-indazole-3-carboxamide or
280280 N-(adamantan-2-yl)-1H-indazole-3-carboxamide by substitution at
281281 the 1-position nitrogen atom of the indazole ring by alkyl,
282282 haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
283283 cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
284284 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
285285 2-(4-morpholinyl)alkyl, whether or not further substituted in the
286286 indazole ring to any extent, whether or not substituted in the
287287 adamantyl ring to any extent, including:
288288 5-Fluoro AKB-48; and
289289 AKB-48;
290290 Aminooxobutylindazolecarboxamide: any compound
291291 structurally derived from
292292 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide
293293 by substitution at the 1-position nitrogen atom of the indazole
294294 ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
295295 haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
296296 cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
297297 (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or
298298 not further substituted in the indazole ring to any extent,
299299 including:
300300 AB-PINACA; and
301301 AB-FUBINACA;
302302 Tetramethylcyclopropylindole: any compound
303303 structurally derived from
304304 3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole by substitution
305305 at the nitrogen atom of the indole ring by alkyl, haloalkyl, benzyl,
306306 halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
307307 hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
308308 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
309309 2-(4-morpholinyl)alkyl, whether or not further substituted in the
310310 indole ring to any extent, whether or not substituted in the
311311 tetramethylcyclopropyl ring to any extent, including:
312312 A-834,735;
313313 A-796,260;
314314 AB-005;
315315 UR-144;
316316 5-Bromo UR-144;
317317 5-Chloro UR-144; and
318318 5-Fluoro UR-144 (Other name: XLR-11);
319319 Tetramethylcyclopropane-thiazole carboxamide: any
320320 compound structurally derived from
321321 2,2,3,3-tetramethyl-N-(thiazol-2-ylidene)cyclopropanecarboxamide
322322 by substitution at the nitrogen atom of the thiazole ring by alkyl,
323323 haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
324324 cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
325325 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
326326 2-(4-morpholinyl)alkyl, whether or not further substituted in the
327327 thiazole ring to any extent, whether or not substituted in the
328328 tetramethylcyclopropyl ring to any extent, including:
329329 A-836,339;
330330 Quinolinylindolecarboxylate: any compound structurally
331331 derived from quinolin-8-yl indole-3-carboxylate by substitution at
332332 the nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl,
333333 halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
334334 hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
335335 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
336336 2-(4-morpholinyl)alkyl, whether or not further substituted in the
337337 indole ring to any extent, whether or not substituted in the
338338 quinoline ring to any extent, including:
339339 BB-22;
340340 5-Fluoro PB-22; and
341341 PB-22;
342342 Cyclohexylphenol: any compound [cyclohexylphenols]
343343 structurally derived from 2-(3-hydroxycyclohexyl)phenol by
344344 substitution at the 5-position of the phenolic ring by alkyl,
345345 haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
346346 cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
347347 (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
348348 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl], whether or not
349349 substituted in the cyclohexyl ring to any extent, including:
350350 CP-55,940;
351351 CP-47,497;
352352 analogues of CP-47,497, including VII, V, VIII, I,
353353 II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
354354 JWH-337;
355355 JWH-344;
356356 JWH-345; and
357357 JWH-405; and
358358 cannabinol derivatives, except where contained in
359359 marihuana, including tetrahydro derivatives of cannabinol and
360360 3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
361361 such as:
362362 Nabilone;
363363 HU-210; and
364364 HU-211[; and
365365 [WIN-55,212-2].
366366 SECTION 3. Section 481.106, Health and Safety Code, is
367367 amended to read as follows:
368368 Sec. 481.106. CLASSIFICATION OF CONTROLLED SUBSTANCE
369369 ANALOGUE. For the purposes of the prosecution of an offense under
370370 this subchapter involving the manufacture, delivery, or possession
371371 of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A
372372 include a controlled substance analogue that:
373373 (1) has a chemical structure substantially similar to
374374 the chemical structure of a controlled substance listed in the
375375 applicable penalty group; or
376376 (2) is specifically designed to produce an effect
377377 substantially similar to, or greater than, a controlled substance
378378 listed in the applicable penalty group.
379379 SECTION 4. The change in law made by this Act applies only
380380 to an offense committed on or after the effective date of this Act.
381381 An offense committed before the effective date of this Act is
382382 governed by the law in effect on the date the offense was committed,
383383 and the former law is continued in effect for that purpose. For
384384 purposes of this section, an offense was committed before the
385385 effective date of this Act if any element of the offense occurred
386386 before that date.
387387 SECTION 5. This Act takes effect September 1, 2013.